Overview

Ablation Devices Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

The ablation therapies are used for treating different diseases like cancer, gynaecological diseases, ophthalmic diseases and cardiovascular diseases. It is less painful than traditional surgeries as it a minimally invasive process resulting in the reduction of recovery times. Additionally, it causes less damage to the tissues surrounding the affected area. Although it lowers the side effects, it has certain disadvantages like ablation devices cannot treat bulky and large tissues like neck and bone nodules and these devices are not available in remote locations. Furthermore, the rising prevalence of patients with cardiovascular diseases in developed countries like the United States shall boost the ablation devices market growth. According to a data provided by St. Jude Medical Inc., over 240,000 catheter ablations were performed in the United States while over 980,000 patients were treated using ablation devices across the world. Moreover, the increased prevalence of cancer shall propel the market growth. As per the WHO, the number of newly registered cases are predicted to rise by over 65% in twenty years. Such an escalating prevalence of chronic diseases shall contribute to the proliferation of the market.
Ablation Devices Market
Market Segmentation:

By Technology

  • Thermal Ablation
  • Non-Thermal Ablation

By Procedure

  • Aesthetics skin Rejuvenation and Tightening
  • Aesthetics Body Sculpting, Fat Reduction and Reduction in the Appearance of Cellulite
  • Benign Prostatic Hyperplasia
  • Transurethral Needle Ablation
  • Laser and Other Energy-Based Therapies/Holmium Laser Ablation
  • Stress Urinary Incontinence
  • Menorrhagia
  • Uterine Fibroids
  • Varicose Veins’
  • Atrial Fibrillation          

By Function

  • Automated
  • Conventional 

By Application

  • Cancer
  • Cardiovascular
  • Ophthalmology
  • Gynecology
  • Urology
  • Orthopedics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


The market is classified into technology, procedure, function, application and region. The technology segment is fragmented into thermal and non-thermal ablation. The thermal segment is classified into electrical, radiofrequency, radiation, light, microwave, hydrothermal while the nonthermal ablation is divided into hydromechanical and cryoablation. The application segment is bifurcated into cancer, cardiovascular, ophthalmology, gynaecology, urology, orthopaedics and others. The procedure segment is classified into aesthetic body sculpting, aesthetics skin rejuvenation, reduction in the appearance of cellulite, transurethral needle ablation, benign prostatic hyperplasia, laser and other helium laser ablations, energy-based therapies. The function segment is fragmented into automated and conventional ablation devices.

Regional Analysis:

The North America region is expected to lead the market during the forecasted timeframe owing to a strong presence of major market players in the region. Furthermore, unhealthy dietary habits, lack of exercise and rising geriatric population has increased the number of patients diagnosed with cardiovascular diseases in the region. Many key players and even emerging companies have focussed on increasing their research and development activities in the region. For example, Medtronic Inc. announced their new radiofrequency ablation catheter Barrx 360 Express in April 2016. It is an RFA catheter that is self-adjusting and is used for removing diseases tissues.

Competitive Landscape:

Some of the key market players are St. Jude Medical Inc., Medtronic plc, Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Conmed Corporation, Olympus Corporation, Smith & Nephew plc, BTG plc, Johnson & Johnson, Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra LifeSciences Holdings Corporation, Abbott Laboratories, Terumo Corporation.

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the global ablation devices market by technology, by application, by function, by procedure and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics